πŸ‡ΊπŸ‡Έ FDA
Patent

US 7422755

Antimultiorganism glycoconjugate vaccine

granted A61KA61K2039/6081A61K39/07

Quick answer

US patent 7422755 (Antimultiorganism glycoconjugate vaccine) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/6081, A61K39/07